Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 420


Rheumatoid arthritis.

Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K.

Nat Rev Dis Primers. 2018 Feb 8;4:18001. doi: 10.1038/nrdp.2018.1. Review.


Risk of infantile hemangiomas in the offspring of women with autoimmune disease and the pathogenic implications of these lesions.

Smith CJF, Jones KL, Johnson DL, Bandoli G, Robinson LK, Kavanaugh A, Chambers CD.

Am J Med Genet A. 2018 Mar;176(3):570-577. doi: 10.1002/ajmg.a.38594. Epub 2018 Jan 17.


Three-dimensional ultrashort echo time cones (3D UTE-Cones) magnetic resonance imaging of entheses and tendons.

Chen B, Zhao Y, Cheng X, Ma Y, Chang EY, Kavanaugh A, Liu S, Du J.

Magn Reson Imaging. 2018 Jan 5;49:4-9. doi: 10.1016/j.mri.2017.12.034. [Epub ahead of print]


Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial.

Mease PJ, Kavanaugh A, Coates LC, McInnes IB, Hojnik M, Zhang Y, Anderson JK, Dorr AP, Gladman DD.

RMD Open. 2017 Jul 18;3(1):e000415. doi: 10.1136/rmdopen-2016-000415. eCollection 2017.


Characteristics of a National Level Female Weightlifter Peaking for Competition: A Case Study.

Bazyler CD, Mizuguchi S, Zourdos MC, Sato K, Kavanaugh AA, DeWeese BH, Breuel KF, Stone MH.

J Strength Cond Res. 2017 Dec 1. doi: 10.1519/JSC.0000000000002379. [Epub ahead of print]


Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.

Coates LC, FitzGerald O, Merola JF, Smolen J, van Mens LJJ, Bertheussen H, Boehncke WH, Callis Duffin K, Campbell W, de Wit M, Gladman D, Gottlieb A, James J, Kavanaugh A, Kristensen LE, Kvien TK, Luger T, McHugh N, Mease P, Nash P, Ogdie A, Rosen CF, Strand V, Tillett W, Veale DJ, Helliwell PS.

Arthritis Rheumatol. 2017 Nov 28. doi: 10.1002/art.40391. [Epub ahead of print]


Rheumatoid arthritis: Do TNF inhibitors influence lymphoma development?

Kavanaugh A.

Nat Rev Rheumatol. 2017 Nov 21;13(12):697-698. doi: 10.1038/nrrheum.2017.186. No abstract available.


Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis.

Kavanaugh A, van Vollenhoven RF, Fleischmann R, Emery P, Sainsbury I, Florentinus S, Chen S, Guérette B, Kupper H, Smolen JS.

Ann Rheum Dis. 2018 Feb;77(2):289-292. doi: 10.1136/annrheumdis-2017-211871. Epub 2017 Nov 16.


Value of RAPID3 in patients with PsA: results from the TICOPA and LOPAS II databases.

Coates LC, Tillett W, Shaddick G, Pincus T, Kavanaugh A, Helliwell PS.

Arthritis Care Res (Hoboken). 2017 Nov 7. doi: 10.1002/acr.23460. [Epub ahead of print]


Returners Exhibit Greater Jumping Performance Improvements During a Peaking Phase Compared to New Players on a Volleyball Team.

Bazyler CD, Mizuguchi S, Kavanaugh AA, McMahon JJ, Comfort P, Stone MH.

Int J Sports Physiol Perform. 2017 Oct 16:1-26. doi: 10.1123/ijspp.2017-0474. [Epub ahead of print]


Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone.

Keystone EC, Breedveld FC, van der Heijde D, van Vollenhoven RF, Emery P, Smolen JS, Sainsbury I, Florentinus S, Kupper H, Chen K, Kavanaugh A.

RMD Open. 2017 Sep 26;3(2):e000445. doi: 10.1136/rmdopen-2017-000445. eCollection 2017.


Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials.

Strand V, Michalska M, Birchwood C, Pei J, Tuckwell K, Finch R, Gabay C, Kavanaugh A, Jones G.

RMD Open. 2017 Sep 14;3(2):e000496. doi: 10.1136/rmdopen-2017-000496. eCollection 2017.


Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab.

Burmester GR, Kaeley GS, Kavanaugh AF, Gabay C, MacCarter DK, Nash P, Takeuchi T, Goss SL, Rodila R, Chen K, Kupper H, Kalabic J.

RMD Open. 2017 Sep 17;3(2):e000465. doi: 10.1136/rmdopen-2017-000465. eCollection 2017.


Bone mineral density in patients with psoriatic arthritis: data from the Nord-Trøndelag Health Study 3.

Gulati AM, Hoff M, Salvesen Ø, Dhainaut A, Semb AG, Kavanaugh A, Haugeberg G.

RMD Open. 2017 Jul 13;3(1):e000413. doi: 10.1136/rmdopen-2016-000413. eCollection 2017.


Achilles enthesitis defined by ultrasound is not associated with clinical enthesitis in patients with psoriatic arthritis.

Michelsen B, Diamantopoulos AP, Soldal DM, Hammer HB, Kavanaugh A, Haugeberg G.

RMD Open. 2017 Aug 16;3(2):e000486. doi: 10.1136/rmdopen-2017-000486. eCollection 2017.


Long-Term Changes in Jump Performance and Maximum Strength in a Cohort of National Collegiate Athletic Association Division I Women's Volleyball Athletes.

Kavanaugh AA, Mizuguchi S, Sands WA, Ramsey MW, Stone MH.

J Strength Cond Res. 2018 Jan;32(1):66-75. doi: 10.1519/JSC.0000000000002214.


Jumping Performance is Preserved, but not Muscle Thickness in Collegiate Volleyball Players After a Taper.

Bazyler CD, Mizuguchi S, Sole CJ, Suchomel TJ, Sato K, Kavanaugh AA, DeWeese BH, Stone MH.

J Strength Cond Res. 2017 May 25. doi: 10.1519/JSC.0000000000001912. [Epub ahead of print]


Radiographic progression is less in psoriatic arthritis achieving a good response to treatment: data using newer composite indices of disease activity.

Helliwell PS, Kavanaugh A.

Arthritis Care Res (Hoboken). 2017 Aug 22. doi: 10.1002/acr.23345. [Epub ahead of print]


Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout.

Calabrese LH, Kavanaugh A, Yeo AE, Lipsky PE.

Arthritis Res Ther. 2017 Aug 17;19(1):191. doi: 10.1186/s13075-017-1396-8.


Safety and Efficacy of Intravenous Golimumab in Patients With Active Psoriatic Arthritis: Results Through Week Twenty-Four of the GO-VIBRANT Study.

Kavanaugh A, Husni ME, Harrison DD, Kim L, Lo KH, Leu JH, Hsia EC.

Arthritis Rheumatol. 2017 Nov;69(11):2151-2161. doi: 10.1002/art.40226.


Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.

Smolen JS, Schöls M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landewé R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, Bosch FVD, Coates LC, Emery P, Gensler LS, Gossec L, Helliwell P, Jongkees M, Kvien TK, Inman RD, McInnes IB, Maccarone M, Machado PM, Molto A, Ogdie A, Poddubnyy D, Ritchlin C, Rudwaleit M, Tanew A, Thio B, Veale D, Vlam K, Heijde DV.

Ann Rheum Dis. 2018 Jan;77(1):3-17. doi: 10.1136/annrheumdis-2017-211734. Epub 2017 Jul 6. Erratum in: Ann Rheum Dis. 2018 Mar;77(3):472.


Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry.

Mease PJ, Karki C, Palmer JB, Etzel CJ, Kavanaugh A, Ritchlin CT, Malley W, Herrera V, Tran M, Greenberg JD.

J Rheumatol. 2017 Aug;44(8):1151-1158. doi: 10.3899/jrheum.160963. Epub 2017 Jun 15.


International Treatment Recommendations Update: A Report from the GRAPPA 2016 Annual Meeting.

Coates LC, Chandran V, Ogdie A, O'Sullivan D, Brooke M, Steinkoenig I, Mease PJ, Ritchlin CT, Kavanaugh A.

J Rheumatol. 2017 May;44(5):684-685. doi: 10.3899/jrheum.170144.


Proceedings of the GRAPPA 2016 Retreat.

Jadon DR, Gladman DD, Mease PJ, FitzGerald O, Chandran V, Goel N, Rosen CF, Maksymowych WP, Ritchlin CT, Ogdie A, Coates LC, Cauli A, Soriano ER, Husni ME, Campbell W, Azevedo VF, Callis Duffin K, Armstrong AW, Gottlieb AB, Kavanaugh A, Garg A, Helliwell PS.

J Rheumatol. 2017 May;44(5):668-673. doi: 10.3899/jrheum.170141.


Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment.

Smith CJF, Friedlander SF, Guma M, Kavanaugh A, Chambers CD.

Birth Defects Res. 2017 Jul 3;109(11):809-815. doi: 10.1002/bdr2.1023. Epub 2017 Apr 12. Review.


Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.

Mease PJ, Karki C, Palmer JB, Etzel CJ, Kavanaugh A, Ritchlin CT, Malley W, Herrera V, Tran M, Greenberg JD.

Arthritis Care Res (Hoboken). 2017 Nov;69(11):1692-1699. doi: 10.1002/acr.23249.


Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry.

Kavanaugh A, Keystone E, Greenberg JD, Reed GW, Griffith JM, Friedman AW, Saunders KC, Ganguli A.

Rheumatology (Oxford). 2017 Jul 1;56(7):1095-1101. doi: 10.1093/rheumatology/kex042.


Magic angle effect plays a major role in both T1rho and T2 relaxation in articular cartilage.

Shao H, Pauli C, Li S, Ma Y, Tadros AS, Kavanaugh A, Chang EY, Tang G, Du J.

Osteoarthritis Cartilage. 2017 Dec;25(12):2022-2030. doi: 10.1016/j.joca.2017.01.013. Epub 2017 Feb 1.


Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.

Michelsen B, Diamantopoulos AP, Høiberg HK, Soldal DM, Kavanaugh A, Haugeberg G.

J Rheumatol. 2017 Apr;44(4):431-436. doi: 10.3899/jrheum.160973. Epub 2017 Feb 1.


Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritis.

Huynh DH, Boyd TA, Etzel CJ, Cox V, Kremer J, Mease P, Kavanaugh A.

RMD Open. 2017 Jan 16;3(1):e000395. doi: 10.1136/rmdopen-2016-000395. eCollection 2017.


New GRAPPA and EULAR recommendations for the management of psoriatic arthritis.

Coates LC, Gossec L, Ramiro S, Mease P, van der Heijde D, Smolen JS, Ritchlin C, Kavanaugh A.

Rheumatology (Oxford). 2017 Aug 1;56(8):1251-1253. doi: 10.1093/rheumatology/kew390. No abstract available.


Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2).

Kavanaugh A, Kremer J, Ponce L, Cseuz R, Reshetko OV, Stanislavchuk M, Greenwald M, Van der Aa A, Vanhoutte F, Tasset C, Harrison P.

Ann Rheum Dis. 2017 Jun;76(6):1009-1019. doi: 10.1136/annrheumdis-2016-210105. Epub 2016 Dec 19.


Modern Techniques and Technologies Applied to Training and Performance Monitoring.

Sands WA, Kavanaugh AA, Murray SR, McNeal JR, Jemni M.

Int J Sports Physiol Perform. 2017 Apr;12(Suppl 2):S263-S272. doi: 10.1123/ijspp.2016-0405. Epub 2016 Dec 5. Review.


Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations.

Gossec L, Coates LC, de Wit M, Kavanaugh A, Ramiro S, Mease PJ, Ritchlin CT, van der Heijde D, Smolen JS.

Nat Rev Rheumatol. 2016 Dec;12(12):743-750. doi: 10.1038/nrrheum.2016.183. Epub 2016 Nov 10. Review.


Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.

Martin G, Strober BE, Leonardi CL, Gelfand JM, Blauvelt A, Kavanaugh A, Stein Gold L, Berman B, Rosen T, Stockfleth E.

J Clin Aesthet Dermatol. 2016 Sep;9(9 Suppl 1):S5-S29. Epub 2016 Sep 1. No abstract available.


Ustekinumab Treatment and Improvement of Physical Function and Health-Related Quality of Life in Patients With Psoriatic Arthritis.

Rahman P, Puig L, Gottlieb AB, Kavanaugh A, McInnes IB, Ritchlin C, Li S, Wang Y, Song M, Mendelsohn A, Han C; PSUMMIT 1 and 2 Study Groups.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1812-1822. doi: 10.1002/acr.23000. Epub 2016 Oct 21.


Information technology in rheumatology.

Pincus T, Braun J, Kavanaugh A, Ravelli A, Smolen JS.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):1. Epub 2016 Oct 18. No abstract available.


Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.

Kavanaugh A, Helliwell P, Ritchlin CT.

Rheumatol Ther. 2016 Jun;3(1):91-102. doi: 10.1007/s40744-016-0029-z. Epub 2016 Feb 29.


Adult Inflammatory Arthritides: What the Radiologist Should Know.

Chang EY, Chen KC, Huang BK, Kavanaugh A.

Radiographics. 2016 Oct;36(6):1849-1870. Review.


Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study.

Kavanaugh A, Mease PJ, Reimold AM, Tahir H, Rech J, Hall S, Geusens P, Wang Z, Pricop L, Mpofu S; FUTURE-1 Study Group.

Arthritis Care Res (Hoboken). 2017 Mar;69(3):347-355. doi: 10.1002/acr.23111.


Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis.

Sweeney SR, Kavanaugh A, Lodi A, Wang B, Boyle D, Tiziani S, Guma M.

RMD Open. 2016 Aug 16;2(2):e000289. doi: 10.1136/rmdopen-2016-000289. eCollection 2016.


Changes in Muscle Architecture, Explosive Ability, and Track and Field Throwing Performance Throughout a Competitive Season and After a Taper.

Bazyler CD, Mizuguchi S, Harrison AP, Sato K, Kavanaugh AA, DeWeese BH, Stone MH.

J Strength Cond Res. 2017 Oct;31(10):2785-2793. doi: 10.1519/JSC.0000000000001619.


Secukinumab for the treatment of psoriatic arthritis.

Baronaite Hansen R, Kavanaugh A.

Expert Rev Clin Immunol. 2016 Oct;12(10):1027-36. doi: 10.1080/1744666X.2016.1224658. Epub 2016 Aug 25. Review.


Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis.

Fleischmann RM, Huizinga TW, Kavanaugh AF, Wilkinson B, Kwok K, DeMasi R, van Vollenhoven RF.

RMD Open. 2016 Jul 26;2(2):e000262. doi: 10.1136/rmdopen-2016-000262. eCollection 2016.


Effects of Short-Term Free-Weight and Semiblock Periodization Resistance Training on Metabolic Syndrome.

South MA, Layne AS, Stuart CA, Triplett NT, Ramsey M, Howell ME, Sands WA, Mizuguchi S, Hornsby WG 3rd, Kavanaugh AA, Stone MH.

J Strength Cond Res. 2016 Oct;30(10):2682-96. doi: 10.1519/JSC.0000000000001570.


Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study.

Kavanaugh A, McInnes IB, Mease PJ, Hall S, Chinoy H, Kivitz AJ, Wang Z, Mpofu S.

J Rheumatol. 2016 Sep;43(9):1713-7. doi: 10.3899/jrheum.160275. Epub 2016 Jun 15.


Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate.

Emery P, Smolen JS, Ganguli A, Meerwein S, Bao Y, Kupper H, Chen N, Kavanaugh A.

Rheumatology (Oxford). 2016 Aug;55(8):1458-65. doi: 10.1093/rheumatology/kew056. Epub 2016 Apr 25.


Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2).

Kavanaugh A, Puig L, Gottlieb AB, Ritchlin C, You Y, Li S, Song M, Randazzo B, Rahman P, McInnes IB.

Ann Rheum Dis. 2016 Nov;75(11):1984-1988. doi: 10.1136/annrheumdis-2015-209068. Epub 2016 Apr 20.


Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity.

Michelsen B, Diamantopoulos AP, Hammer HB, Soldal DM, Kavanaugh A, Haugeberg G.

Ann Rheum Dis. 2016 Dec;75(12):2108-2113. doi: 10.1136/annrheumdis-2015-208806. Epub 2016 Apr 18.


Alterations in immune function with biologic therapies for autoimmune disease.

Her M, Kavanaugh A.

J Allergy Clin Immunol. 2016 Jan;137(1):19-27. doi: 10.1016/j.jaci.2015.10.023. Review.


Supplemental Content

Loading ...
Support Center